These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 16810119)

  • 21. 12th Retrovirus Conference. Viramune to prevent mother-to-child transmission. Moving from to consensus.
    Vázquez E
    Posit Aware; 2005; 16(3):28, 31. PubMed ID: 16477707
    [No Abstract]   [Full Text] [Related]  

  • 22. Pregnant women eligible for single-dose nevirapine study.
    James JS
    AIDS Treat News; 1997 Oct; (No 280):4. PubMed ID: 11364737
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Determinants of nonadherence to a single-dose nevirapine regimen for the prevention of mother-to-child HIV transmission in Rwanda.
    Delvaux T; Elul B; Ndagije F; Munyana E; Roberfroid D; Asiimwe A
    J Acquir Immune Defic Syndr; 2009 Feb; 50(2):223-30. PubMed ID: 19131884
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Two-dose intrapartum/newborn nevirapine and standard antiretroviral therapy to reduce perinatal HIV transmission: a randomized trial.
    Dorenbaum A; Cunningham CK; Gelber RD; Culnane M; Mofenson L; Britto P; Rekacewicz C; Newell ML; Delfraissy JF; Cunningham-Schrader B; Mirochnick M; Sullivan JL;
    JAMA; 2002 Jul; 288(2):189-98. PubMed ID: 12095383
    [TBL] [Abstract][Full Text] [Related]  

  • 25. FDA advisory on nevirapine.
    AIDS Treat News; 2005 Jan; (409):7. PubMed ID: 15791716
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nevirapine misinformation: will it kill?
    James JS
    AIDS Treat News; 2004; (407-408):9-13. PubMed ID: 15717386
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HIV drug resistance in mothers and infants following use of antiretrovirals to prevent mother-to-child transmission.
    Ton Q; Frenkel L
    Curr HIV Res; 2013 Mar; 11(2):126-36. PubMed ID: 23432488
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Study offers hope for Africa's next generation.
    WORLD; 1999 Sep; (No 101):4-5. PubMed ID: 11366948
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Nevirapine as an important component of therapy for HIV infection].
    Kravchenko AV
    Vopr Virusol; 2009; 54(6):41. PubMed ID: 20030282
    [No Abstract]   [Full Text] [Related]  

  • 30. Mother-to-child HIV transmission in resource poor settings: how to improve coverage?
    Temmerman M; Quaghebeur A; Mwanyumba F; Mandaliya K
    AIDS; 2003 May; 17(8):1239-42. PubMed ID: 12819526
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Policy. 3 steps can drastically reduce mother-to-child transmission.
    AIDS Policy Law; 2012 Mar; 27(4):3. PubMed ID: 22550637
    [No Abstract]   [Full Text] [Related]  

  • 32. Let nevirapine do what it does best.
    Huff B
    GMHC Treat Issues; 2002 Mar; 16(3):10-1. PubMed ID: 12004796
    [No Abstract]   [Full Text] [Related]  

  • 33. Single-dose Nevirapine during pregnancy.
    Sax PE
    AIDS Clin Care; 1999 Oct; 11(10):84-5. PubMed ID: 11366708
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nevirapine Pharmacokinetics in Neonates Between 25 and 32 Weeks Gestational Age for the Prevention of Mother-to-Child Transmission of HIV.
    Hirt D; Kubota Kilengelela J; Jarreau PH; Tréluyer JM; Marcou V
    Pediatr Infect Dis J; 2021 Apr; 40(4):344-346. PubMed ID: 33710978
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Short postexposure prophylaxis in newborn babies to reduce mother-to-child transmission of HIV-1: NVAZ randomised clinical trial.
    Taha TE; Kumwenda NI; Gibbons A; Broadhead RL; Fiscus S; Lema V; Liomba G; Nkhoma C; Miotti PG; Hoover DR
    Lancet; 2003 Oct; 362(9391):1171-7. PubMed ID: 14568737
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Perinatal HIV prevention.
    Stephenson J
    JAMA; 1999 Aug; 282(7):625. PubMed ID: 10532854
    [No Abstract]   [Full Text] [Related]  

  • 37. Nevirapine concentration in cervicovaginal and oropharyngeal secretions after single-dose administration to the mother.
    Harms G; Kunz A; Karcher H; Mugenyi K; Kurowski M
    Antivir Ther; 2005; 10(6):777. PubMed ID: 16218178
    [No Abstract]   [Full Text] [Related]  

  • 38. Single-dose perinatal nevirapine plus standard zidovudine to prevent mother-to-child transmission of HIV-1 in Thailand.
    Lallemant M; Jourdain G; Le Coeur S; Mary JY; Ngo-Giang-Huong N; Koetsawang S; Kanshana S; McIntosh K; Thaineua V;
    N Engl J Med; 2004 Jul; 351(3):217-28. PubMed ID: 15247338
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quantifying the impact of nevirapine-based prophylaxis strategies to prevent mother-to-child transmission of HIV-1: a combined pharmacokinetic, pharmacodynamic, and viral dynamic analysis to predict clinical outcomes.
    Frank M; von Kleist M; Kunz A; Harms G; Schütte C; Kloft C
    Antimicrob Agents Chemother; 2011 Dec; 55(12):5529-40. PubMed ID: 21947390
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of nevirapine (NVP) resistance mutations and HIV type 1 subtype in women from Abidjan (Côte d'Ivoire) after NVP single-dose prophylaxis of HIV type 1 mother-to-child transmission.
    Toni TD; Masquelier B; Lazaro E; Dore-Mbami M; Ba-Gomis FO; Téa-Diop Y; Kouakou K; Diby J; Sia E; Soppi S; Essien S; Schrive MH; Pinson P; Chenal H; Fleury HJ
    AIDS Res Hum Retroviruses; 2005 Dec; 21(12):1031-4. PubMed ID: 16379606
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.